Transactions

Intas Pharmaceuticals Ltd.’s acquisition of the generics business of Actavis in the UK & Ireland from Teva Pharmaceutical Industries Ltd.

Date Announced:
10/05/2016

client:
Intas Pharmaceuticals Ltd.

Status:
Closed – 01/2017

Value:
£603 million